Exchange: NASDAQ·Updated 02:44 PM EST
KMB logo

KMB Kimberly-Clark Corp.

$107.48
$0.67
(0.62%)
Today
Reported EarningsNov 5
Mkt Cap$66.37B
Vol2.82M

About KMB

Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through North America and International Personal Care segments. The North America segment consists of products encompassing each of daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. The International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care, and Feminine Care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Dallas, TX.
38

Bearish Sentiment

How do you feel about KMB?

topstockalerts
CNBC’s Jim Cramer believes investors should diversify beyond technology and AI stocks by increasing exposure to consumer staples while the tech sector struggles. He highlighted four stocks: Kimberly-Clark: Cramer sees significant upside from its pending merger with Kenvue, which could generate cost efficiencies and create a consumer products powerhouse. Shares rose nearly 11% in October but trade below 15x earnings, with a 4.7% dividend yield. He believes the rally has further room to run. Procter & Gamble: Better-than-expected quarterly results and confidence in new CEO Shailesh Jejurikar support the stock. Shares gained 11% in October, although Cramer prefers Kimberly-Clark's cheaper valuation and higher dividend yield. Constellation Brands: Its beer business is gaining market share, while wine and spirits shipments grew 15% last quarter. Shares surged 20% in October, but Cramer still sees value at approximately 11x earnings and a dividend yield above 3%. $KMB $PG $STZ
3
Alphasearch
$KMB $KHC $CPB My Consumer Staple strategy is working. So is having no Semi exposure as I predicted in October the bubble would burst. My only regret was holding ORCL and SMCI too long, but at least I sold. Good article in WSJ on KHC announcing $700 million investment in the business. As part of this year’s spending boost, $325 million went to marketing, $250 million to lowering prices, $75 million to personnel, and $50 million to improving existing products and developing new ones. New product Cheezy Ramen recently sold out within a week of its launch in Canada. Getting paid while I wait and getting capital gains in all of these with KBM almost 11%. https://www.wsj.com/business/retail/kraft-heinz-has-a-comeback-plan-cheesy-ramen-and-high-protein-jell-o-6fbfc2f8?mod=itp_wsj
2
FrostyEmpire4
$KMB ..so if earnings are bad...I get to buy more at a cheaper price. If earnings are good, I am happy I bought when I did. It's not a bad position to be in.
2
Parmesan
$KMB Maybe they can make a new super absorbent wipe that can use to clean up all the droppings from Sayed, AOC and other highly qualified new Congress folks. Would be EPA approved.
1
LiveSquawk
$KMB | Kimberly-Clark Q3 2026 Earnings - Net Sales: $4.13B (est $4.11B) - Adj Oper Profit: $677.0M (est $690.7M) - Adj EPS: $1.70 - Reaffirms 2026 Standalone Outlook
1
Equireason
$KMB Kenvue is officially in. The closing 8-K (Nov 2) lines up the promise against the cost: ✅ synergy target reaffirmed at ~USD 2.1B run-rate: ~USD 1.9B cost synergies within 3 years of close, ~USD 0.5B profit from revenue synergies, minus ~USD 0.3B reinvestment, within 4 years ❌ the bill: ~USD 3.1B pre-tax charges through 2029 (USD 2.5B of it cash) plus ~USD 1.4B capex. Biggest cash buckets: supply chain ~0.8B, ERP/tech ~0.6B, workforce ~0.4B, advisors ~0.4B ❌ the 8-K also flags possible charges "not currently contemplated" Kenvue holders got 0.14625 KMB shares + 3.50 dollars cash per share. Math: about 2 years of full run-rate synergies pays for the integration, but the spending comes first. How long do you give them before you want to see it in margins?
1
openclassaction2
$KMB: that $5 Cottonelle card says Armstrong v. Kimberly-Clark for a reason. It is the no-proof tier, Kroll administered. Real payments never ask for a fee or bank login to unlock them. Claims closed. Open Class Actions.
1
parcha
https://www.cnbc.com/2026/10/30/jim-cramer-week-ahead-apple-amd-jobs-report.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension $KMB Thursday Kimberly-Clark reports, with Cramer optimistic about the consumer products company’s prospects following its planned merger with Kenvue. The stock has benefited from investors rotating into consumer staples, and Cramer remains bullish on the company. “If this one falls before then, I think you should pick some up,” he said.
1
parcha
https://www.cnbc.com/2026/10/30/jim-cramer-consumer-staples-stocks.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension $KMB Kimberly-Clark: The maker of Kleenex tissues and Huggies diapers is one of the newest holdings in Cramer’s Charitable Trust, the portfolio run by CNBC’s Investing Club. Cramer sees significant upside from its pending merger with Kenvue, which owns brands including Tylenol and Band-Aid. He expects the deal to generate efficiencies and create a consumer products powerhouse. Kimberly-Clark shares gained nearly 11% in October, but the stock still trades at less than 15 times earnings, with a 4.7% dividend yield. “I think the move is just getting started,” Cramer said.
1
openclassaction2
$KMB: already got a Kimberly-Clark refund card for those Cottonelle wipes? That prior refund could mean no second Armstrong payment. The $6M to $13.5M deal kept personal injury claims out. Claims closed. Open Class Actions.
1
openclassaction2
$KMB: June 2026 update on Cottonelle: $5 prepaid cards are still being reported by Armstrong class members, years after final approval. That card is the no-proof payment, not a new claim offer. Claims closed. Open Class Actions.
1
parcha
https://www.cnbc.com/investingclub/2026/11/17/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension $KMB JPMorgan resumed coverage of Kleenex maker Kimberly-Clark with a neutral rating and price target of $129. We own this one as part of our defensive exposure for the Club, seeing a lot of potential in the Kenvue acquisition. With issues facing both Kimberly-Clark’s legacy business and Tylenol owner Kenvue, JPMorgan believes the burden of proof is on execution. I’m betting that CEO Michael Hsu can get it done.
Chartist0_0
$KMB So many people playing the old winners and are missing the transition. KMB to 129$ by Easter Sunday.
Chartist0_0
$KMB while KMB may have to digest this move up from 95$ for the next couple weeks, it is one of my favorite plays into Memorial Day, 2027.
Parmesan
$KMB what is wrong today, I thought this could only go up? When you are in the house wrap business, interest rates matter. Only natural disasters can create demand while Obama continues to 💩 on the USA.
Parmesan
$KMB How did we get in the house wrap business? Why do we stay? I have 200 shares trying to make a killing here offering operational and strategic insights.
cmgventure
$KMB | KIMBERLY-CLARK CORPORATION Q3 2026 EARNINGS HIGHLIGHTS ◆ EPS: $1.70 vs. $1.65 est. ✅ ◆ Revenue: $4.13B vs. $4.13B est. 🟠 ◆ Net Income: $1,800M (+296.5% YoY) ◆ Operating Income: $516M (-16.9% YoY) ◆ Marketing, Research & General Expenses: $912M (+6.7% YoY) ◆ H1 Operating Cash Flow: $2,408M (+33.5% YoY) Segment Performance: ◆ North America: $2,738M (+0.9% YoY) ◆ International Personal Care: $1,396M (-2.8% YoY) Key Metrics: ◆ The IFP Transaction Gain added a net $3.67 per share to GAAP EPS, which adjusted EPS excludes. ◆ China social media disruption created approximately 270 bps headwind to Q3 organic sales and ~530 bps headwind to adjusted operating profit. ◆ IPC operating profit fell 32.7% to $144M; China disruption alone created approximately 16.8% headwind to IPC operating profit. Forward Guidance: ◆ FY 2026 Organic Sales Growth expected ~100 bps below weighted average category growth of ~1.7% trailing twelve months. ◆ FY 2026 Adjusted Operating Profit expected to grow mid-single digits on a constant-currency basis. ◆ FY 2026 Adjusted EPS from Continuing Operations expected to grow high single digits on a constant-currency basis. ◆ FY 2026 Adjusted EPS Attributable to Kimberly-Clark expected to see a low single digit decline on a constant-currency basis.
StocktwitsEarnings
$KMB Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.70 up 17.24% YoY • Reported revenue of $4.13B down -0.39% YoY • Kimberly-Clark expects 2026 organic sales approximately 100 basis points below weighted average category growth; adjusted operating profit growth mid-single digits, continuing-operations EPS growth high-single digits, and attributable EPS decline low-single digits, constant-currency.
BRNDN
$KMB what a recovery from low 90s. Hopefully she can go back to 120 for even in the 4 year chart lol

Advertisement|Remove ads.